1. Home
  2. GRFS vs PACS Comparison

GRFS vs PACS Comparison

Compare GRFS & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.87

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo PACS Group Inc.

PACS

PACS Group Inc.

HOLD

Current Price

$38.87

Market Cap

6.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
PACS
Founded
1940
2013
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.5B
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
GRFS
PACS
Price
$8.87
$38.87
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$10.15
$39.67
AVG Volume (30 Days)
485.7K
1.2M
Earning Date
07-28-2022
03-13-2026
Dividend Yield
1.60%
N/A
EPS Growth
N/A
176.35
EPS
0.64
1.04
Revenue
$8,821,017,248.00
$5,138,841,000.00
Revenue This Year
$5.36
$32.53
Revenue Next Year
$5.15
$7.71
P/E Ratio
$17.46
$37.28
Revenue Growth
7.31
37.58
52 Week Low
$6.19
$7.50
52 Week High
$11.14
$43.08

Technical Indicators

Market Signals
Indicator
GRFS
PACS
Relative Strength Index (RSI) 44.66 60.28
Support Level $8.79 $38.10
Resistance Level $9.40 $43.08
Average True Range (ATR) 0.24 1.86
MACD -0.05 -0.69
Stochastic Oscillator 12.18 26.09

Price Performance

Historical Comparison
GRFS
PACS

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About PACS PACS Group Inc.

PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.

Share on Social Networks: